MFAP5
Microfibrillar-associated protein 5
Also known as: MAGP2, MFAP5_HUMAN, MP25
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13361
- Gene
- MFAP5
- Ensembl
- ENSG00000197614
- Chromosome
- 12
- Canonical length
- 173 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a 25-kD microfibril-associated glycoprotein which is a component of microfibrils of the extracellular matrix. The encoded protein promotes attachment of cells to microfibrils via alpha-V-beta-3 integrin. Deficiency of this gene in mice results in neutropenia. Alternate splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
173 residues, UniProt reviewed canonical sequence.
>Q13361|MFAP5
1 MSLLGPKVLL FLAAFIITSD WIPLGVNSQR GDDVTQATPE TFTEDPNLVN DPATDETVLA
61 VLADIAPSTD DLASLSEKNT TAECWDEKFT CTRLYSVHRP VKQCIHQLCF TSLRRMYIVN
121 KEICSRLVCK EHEAMKDELC RQMAGLPPRR LRRSNYFRLP PCENVDLQRP NGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MFAP5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 185 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 185 nTPM
- adipose tissue: 136 nTPM
- smooth muscle: 133 nTPM
- tongue: 110 nTPM
- placenta: 89 nTPM
- blood vessel: 78 nTPM
Single-cell type
- extravillous trophoblasts: 1,767 nCPM
- fibroblasts: 759 nCPM
- migrating cytotrophoblasts: 466 nCPM
- fibro-adipogenic progenitors: 357 nCPM
- syncytiotrophoblasts: 319 nCPM
- cytotrophoblasts: 114 nCPM
Immune cell
- basophil: 3 nTPM
- neutrophil: 1.1 nTPM
- classical monocyte: 0.8 nTPM
- eosinophil: 0.7 nTPM
- intermediate monocyte: 0.7 nTPM
- non-classical monocyte: 0.6 nTPM
Brain region
- cerebellum: 114 nTPM
- cerebral cortex: 67 nTPM
- white matter: 60 nTPM
- basal ganglia: 55 nTPM
- amygdala: 54 nTPM
- medulla oblongata: 54 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MFAP5.
Disease | AllUniProt
Conditions MFAP5 is implicated in, by any mechanism.
- Aortic aneurysm, familial thoracic 9 (AAT9) MIM:616166
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 328 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial thoracic aortic aneurysm and aortic dissection
- Aortic aneurysm, familial thoracic 9
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MFAP5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MFAP5 as an antibody target. Whether an autoantibody or antibody against MFAP5 could matter depends on whether native MFAP5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MFAP5 is annotated as secreted, so native MFAP5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MFAP5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...